Cost-effectiveness of percutaneous vertebroplasty in osteoporotic vertebral fractures
- 18 July 2008
- journal article
- research article
- Published by Springer Nature in European Spine Journal
- Vol. 17 (9) , 1242-1250
Abstract
A retrospective study was conducted in 179 consecutive patients (48 males, 131 females; mean age: 72.0 ± 8.59 years; range: 51–93) with single symptomatic acute amyelic osteoporotic vertebral fracture presenting between September 2004 and September 2005 to the Santa Lucia Foundation in Rome, Italy. Vertebral fractures usually become manifest due to pain which can be debilitating. Treatment depends on the presence or absence of spinal cord involvement. In the first case, surgical stabilization is mandatory. In the second case, treatment may be performed either by conservative medical therapy (CMT) or percutaneous vertebroplasty (PVT). The aim of this study was to evaluate the effectiveness, costs and cost-effectiveness of percutaneous vertebroplasty. After 2 weeks of analgesic therapy, 153 patients presented refractory pain and were offered treatment by PVT. A total of 58 patients accepted and underwent PVT (PVT group), while 95 refused and underwent conservative medical therapy (CMT group). Follow-up was performed by specialist consults, spine radiography and MRI and a self-assessment questionnaire evaluating pain using a Visual Analogue Scale (VAS) and function using an ambulation and an Activities of Daily Living (ADL) scale. A 12-month follow-up was obtained in 86 of 95 (90.5%) CMT group patients and 54 of 58 (93.1%) PVT group patients. Significant reduction of VAS and improvement of ambulation and ADL was observed in both groups at 1 week and 3 and 12 months (P < 0.05; Wilcoxon signed rank test), however, these results were significantly superior in the PVT group at 1 week and 3 months (P < 0.05; Mann–Whitney U test). Average cost per patient at 1 week and 3 and 12 months were respectively 755.49 ± 661.96, 3791.95 ± 3341.97 and 4299.55 ± 3211.53 € (CMT group) and 3311.35 ± 0.32, 3745.30 ± 3.59 and 4101.05 ± 755.41 € (PVT group). PVT resulted significantly more cost-effective than CMT with regards to the three scales at 1 week (P < 0.05; Mann–Whitney U test). At 3 months PVT was more cost-effective than CMT with regards to the three scales, however, the difference was significant only with regards to ambulation. No significant differences in cost-effectiveness where found between the two groups at 12 months. PVT should be considered the treatment of first choice in symptomatic acute amyelic osteoporotic vertebral fractures with refractory pain after a short period of analgesic therapy.Keywords
This publication has 20 references indexed in Scilit:
- Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplastyClinical Rheumatology, 2004
- Vertebroplasty and kyphoplasty: new equipment for malignant vertebral fractures treatment.2003
- Reduction in the number of repeated operations for the treatment of subacute and chronic subdural hematomas by placement of subdural drainsJournal of Neurosurgery, 2003
- The hospital cost of vertebral fractures in the EU: estimates using national datasetsOsteoporosis International, 2003
- Vertebral Compression Fractures: Pain Reduction and Improvement in Functional Mobility after Percutaneous Polymethylmethacrylate Vertebroplasty—Retrospective Report of 245 CasesRadiology, 2003
- Osteoporotic vertebral fracturesNeurosurgical Focus, 2001
- Vertebral Fractures and Mortality in Older WomenArchives of internal medicine (1960), 1999
- Epidemiology of OsteoporosisOsteoporosis International, 1999
- The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis studyJournal of Bone and Mineral Research, 1996
- The clinical consequences of vertebral compression fractureBone, 1992